Evidence map›Paper›PMID 39761399›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Organic matter and biomarkers: Why are samples required?

Mark A Sephton, Andrew Steele, Frances Westall, Florence Schubotz

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. The scientific value of Mars Sample Return.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mark A SephtonDepartment of Earth Science and Engineering, South Kensington Campus, Imperial College London, London SW7 2AZ, United Kingdom.ORCID 0000-0002-2190-5402
Andrew SteeleGeophysical Laboratory, Carnegie Institution of Washington, Washington, DC 20015.
Frances WestallCentre de Biophysique Moléculaire, Orléans 45071, France.
Florence SchubotzCenter for Marine Environmental Sciences, University of Bremen, 28359 Bremen, Germany.ORCID 0000-0002-5680-1734

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The search for evidence of past prebiotic or biotic activity on Mars will be enhanced by the return of samples to Earth laboratories. While impressive analytical feats have been accomplished by in situ missions on the red planet, accessing the capabilities of Earth's global laboratories will present a step change in data acquisition. Highly diagnostic markers of past life are biomarkers, organic molecules whose architecture can be attributed to once living organisms. Similar organic molecular structures can also be used to identify the prebiotic steps that preceded any emergence of life. The style of modification or degradation of such organic structures indicates their agents of change, including oxidants, radiation, heating, water, and pressure. For biomarker analysis, sample return provides enhanced opportunities for sample preparation and analyte isolation. The augmentation of biomarker data with spatial information provides the opportunity for confirmatory data but is a multistep and multitechnique process best achieved here on Earth. Efficient use of returned samples will benefit from lessons learned on Earth's ancient records and meteorites from Mars. The next decade is a time when analytical capabilities can be improved as we prepare for the delivery of carefully selected and collected extraterrestrial samples containing potential evidence of the development or even emergence of past life on Mars.

Indexed as

BiomarkersExobiologyExtraterrestrial EnvironmentMarsEarth, PlanetOrganic ChemicalsOrigin of LifeBiomarkersOrganic ChemicalsastrobiologyMarsorganicsample return

Identifiers

PMID39761399
PMCPMC11745315

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.